Huang Jiwei, Yuan Yichu, Wang Yanqing, Zhang Jin, Kong Wen, Chen Haige, Chen Yonghui, Huang Yiran
Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Oncotarget. 2017 May 30;8(22):36761-36771. doi: 10.18632/oncotarget.13611.
Hemostatic factors is thought to have a potentially significant role in progression and metastasis of malignant tumors. We investigated the prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (PLR) in localized upper tract urothelial carcinoma (UTUC).
A total of 481 patients who underwent radical nephroureterectomy for localized UTUC (pTa-4N0M0) were identified between January 2002 and June 2013. Patients were assigned a F-PLR score of 0, 1, or 2 based upon the presence of elevated plasma fibrinogen level, an elevated PLR, or both. The association between F-PLR score and clinicopathological variables was analysed.
The optimal cut-off value of plasma fibrinogen and PLR for overall survival stratification was determined to be 4.22 and 241.2. Kaplan-Meier analysis revealed significant differences in cancer specific survival (CSS) and overall survival (OS) among patients with F-PLR scores of 0, 1 and 2. Multivariate analysis identified higher F-PLR score as an independent risk factor for CSS (P < 0.001) and OS (P < 0.001). The estimated c-index of the multivariate model for CSS and OS increased from 0.772 and 0.756 to 0.799 and 0.784 when F-PLR score added, which was higher than fibrinogen level, PLR or neutrophil-to-lymphocyte ratio added.
Preoperative F-PLR score is a negative independent prognostic factor for survival outcomes in patients with localized upper tract urothelial carcinoma. Preoperative F-PLR score may become a useful biomarker, particularly because of its low associated cost and easy accessibility.
止血因子被认为在恶性肿瘤的进展和转移中具有潜在的重要作用。我们研究了术前血浆纤维蛋白原水平和血小板与淋巴细胞比值(PLR)在局限性上尿路尿路上皮癌(UTUC)中的预后价值。
2002年1月至2013年6月期间,共纳入481例行根治性肾输尿管切除术治疗局限性UTUC(pTa - 4N0M0)的患者。根据血浆纤维蛋白原水平升高、PLR升高或两者均有,将患者分为F - PLR评分为0、1或2。分析F - PLR评分与临床病理变量之间的关联。
确定血浆纤维蛋白原和PLR用于总体生存分层的最佳截断值分别为4.22和241.2。Kaplan - Meier分析显示,F - PLR评分为0、1和2的患者在癌症特异性生存(CSS)和总体生存(OS)方面存在显著差异。多因素分析确定较高的F - PLR评分是CSS(P < 0.001)和OS(P < 0.001)的独立危险因素。当加入F - PLR评分时,CSS和OS多因素模型的估计c指数从0.772和0.756分别增加到0.799和0.784,高于加入纤维蛋白原水平、PLR或中性粒细胞与淋巴细胞比值时。
术前F - PLR评分是局限性上尿路尿路上皮癌患者生存结局的负性独立预后因素。术前F - PLR评分可能成为一种有用的生物标志物,特别是因其相关成本低且易于获取。